Dr. Carlozzi is the Director of the Center for Clinical Outcomes Development and Application (CODA). She is an expert in health-related quality of life (HRQOL) computer adaptive test development and in outcomes measurement validation for newly developed measurement systems (the Patient Reported Outcomes Measurement Information System—PROMIS, the Neuro-QOL measurement system, and the National Institutes of Health [NIH] Toolbox).
Dr. Carlozzi’s research focuses on improving outcomes assessment through improvements in test sensitivity, efficiency and clinical utility. Her research portfolio includes two large-scale, multi-site studies funded by NIH (awards total ~$7,000,000), as well as several smaller awards from the NIH, the Department of Education, the CHDI foundation, a private donor, and the Michigan Alzheimer’s Disease Center. Dr. Carlozzi’s NIH awards, including two R01s, involve: 1) developing new computer adaptive tests, and 2) validating PROMIS and Neuro-QOL in clinical populations. Specifically, one project is focused on individuals with Huntington disease, while the other project targets caregivers of individuals with traumatic brain injury. In addition to these studies, she is an investigator for several projects providing HRQOL measurement analysis expertise, measurement selection and evaluation expertise, and/or HRQOL measurement development and validation expertise. Dr. Carlozzi received the prestigious Rosenthal Early Career Award from the American Psychological Association.